The stock is trading at $2.18 significantly higher than the 50 day moving average which is $1.87 and well above the 200 day moving average of $1.87. The 50 day moving average went up $0.31 or +16.78% and the 200 day average moved up $0.31. (NASDAQ:DRIO) shares saw light trading volume with 8,223 shares changing hands by the end of trading on Tuesday. Shares saw a steep decrease in trading volume of 82.08% under the normal average daily volume.
Investors are more bearish recently if you pay attention to the uptick in short interest. The stock had a rise in short interest of 0.44% as of September 29, 2017 from the last reporting period. Short shares grew 586 over that period. With short interest at 134,096 and short average daily volume at 23,992, days to cover is 6.0 and the percentage of shorted shares was 0.01% on September 29.
On August 29, 2017 Aegis Capital began coverage by announcing an initial rating of “Buy”.
In the latest earnings report the EPS was $-0.79 and is expected to be $-0.62 for the current year with 9,754,000 shares presently outstanding. Next quarter’s EPS is expected be $-0.25 and the next full year EPS is projected to be $-0.68.
DarioHealth Corp, formerly Labstyle Innovations Corp, launched on August 11, 2011, is a digital health (mHealth) company. The Company is involved in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Business’s product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter..